What is the best way to transition from bevacizumab to pomalidomide in patients with HHT who have ongoing epistaxis and worsening kidney function on bevacizumab?
Currently receiving bev 5 mg/kg q3 weeks. Should bev and pomalyst overlap for some time given later onset of action of Pomalyst?